Single answer
Is Aspira Womens Health Inc (AWH) a buy or sell?
4starter turns market data into one clear verdict you can act on.
Create a free account to save tickers and track your signals.
Log in to turn on watchlist alerts.
Decision snapshot
Everything you need to act fast, in one glance.
What is the conclusion?
Right now our advanced algorithms say:
Do analysts agree?
We compare consensus targets with today's price.
Consensus target for Aspira Womens Health Inc is $3.30, which is $3.22 (3,924.39%) above the current price today's price.
Low target: $3.30 | High target: $3.30
Company snapshot
A quick overview of the business and its public profile.
Aspira Womens Health Inc together with its subsidiaries engages in developing and commercializing diagnostic tests for gynecologic disease in the United States The company provides OVA1 OVERA and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses It also offers ASPiRA GenetiX a genetic test for the risk of gynecologic cancer In addition the company operates Aspira Synergy a testing platform and cloud service for decentralized access of protein biomarker and hereditary genetic testing and owns and operates ASPiRA LABS a lab that specializes in applying biomarkerbased technologies to address critical needs in the management of gynecologic cancers and disease Further its pipeline products include OVAWatch EndoCheck and OVAInherit The company serves physicians physician office laboratories and national and regional laboratories It has a collaborative research agreement with Baylor Genetics an agreement with Harvard DanaFarber Cancer Institute Brigham and Womens Hospital and Medical University Lodz to evaluate the microRNA technology in combination with Aspira technologies for the development of an early detection test for ovarian cancer and a strategic alliance with Quest Diagnostics Incorporated The company was formerly known as Vermillion Inc and changed its name to Aspira Womens Health Inc in June 2020 Aspira Womens Health Inc was incorporated in 1993 and is headquartered in Austin Texas
Website: https://aspirawh.com
Rates and inflation backdrop
US inflation for January 2026 was 0.17%. Over the last 12 months, inflation is 2.83%. The 10-year yield is 4.04 and is down -0.110 over the last 30 days.
Inflation sensitivity
Debt ratio: 0.35. Cash flow to debt ratio: -2.35. Net profit margin: -115.66%. Inflation risk score: high (0.85/1).
Dividend history check
Yes, Aspira Womens Health Inc pays dividends. Last payment was 2016-12-29 for holders on 2016-12-16. Over 30 payments between 2009 and 2016, total $0.586 with an average of $0.0195 per share. Last dividend was $0.0173.
Trading liquidity
No, the average daily trading liquidity for Aspira Womens Health Inc is $484,876. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.
10-year return check
On Aspira Womens Health Inc, 2016-02-26 had a stock price of $24.00. If you invested back then, your return now would be a loss of $23.92 per share or 99.66%.
Why this answer
We combine price momentum, volatility, and trend signals to simplify the decision to one word.
Signal engine scans price, trend, and momentum indicators.
Targets and sentiment are checked against the live quote.
We keep the output simple: buy, sell, or hold.
Analyst consensus
How Wall Street targets compare to today's price.